Rchr
J-GLOBAL ID:200901098732915840   Update date: Mar. 20, 2024

Oshima Hiroko

オオシマ ヒロコ | Oshima Hiroko
Affiliation and department:
Homepage URL  (1): http://www.kanazawa-u.ac.jp/~ganken/oshima/index.html
Research field  (1): Tumor biology
Research keywords  (4): 転移・悪性化 ,  炎症と発がん ,  消化器がん ,  マウスモデル
Research theme for competitive and other funds  (20):
  • 2023 - 2026 胆管がん発生における線維性微小環境制御機構の探索
  • 2022 - 2026 自然免疫反応とCOX2/PGE2経路による転移微小環境の構築
  • 2019 - 2022 炎症性・線維性微小環境による大腸がん転移促進機構の解明
  • 2016 - 2019 Establishment of novel gastric cancer mouse models
  • 2015 - 2019 Analysis on colon cancer malignant progression using novel mouse models
Show all
Papers (79):
  • Yukinori Ikeda, Hiroko Oshima, Sau Yee Kok, Masanobu Oshima, Yukiko T. Matsunaga. Spatiotemporal observation reveals metastatic tumor-driven vascular remodeling as a potential route to polyclonal colonization. 2024
  • Kaori Yoshimura, Yukinobu Ito, Mina Suzuki, Masafumi Horie, Takumi Nishiuchi, Yukako Shintani-Domoto, Kazuyoshi Shigehara, Hiroko Oshima, Masanobu Oshima, Akiteru Goto, et al. Identification of uromodulin deposition in the stroma of perinephric fibromyxoid nephrogenic adenoma by mass spectrometry. Pathology international. 2024
  • Dong Wang, Mizuho Nakayama, Chang Pyo Hong, Hiroko Oshima, Masanobu Oshima. Gain-of-Function p53 Mutation Acts as a Genetic Switch for TGFβ Signaling-Induced Epithelial-to-Mesenchymal Transition in Intestinal Tumors. Cancer research. 2024. 84. 1. 56-68
  • Sau Yee Kok, Mizuho Nakayama, Atsuya Morita, Hiroko Oshima, Masanobu Oshima. Genetic and nongenetic mechanisms for colorectal cancer evolution. Cancer science. 2023. 114. 9. 3478-3486
  • Atsuya Morita, Mizuho Nakayama, Hiroko Oshima, Masanobu Oshima. In Vitro and In Vivo Models for Metastatic Intestinal Tumors Using Genotype-Defined Organoids. Methods in molecular biology (Clifton, N.J.). 2023. 2691. 19-30
more...
MISC (39):
more...
Lectures and oral presentations  (3):
  • 消化器がんのポリクローナル転移機構
    (第40回 腫瘍病理セミナー・北信がんプロFD講演会 金沢女性研究者フォーラム 2022)
  • The fibrotic microenvironment that promote polyclonal metastasis of intestinal tumors.
    (2021)
  • FOXO3, A latent tumor suppressor of gastric cancer.
    (The 10th FUSCC-CRIKU Joint Symposium on Tumor Biology 2021 2021)
Education (3):
  • 1999 - 熊本大学 薬学博士(論文博士)
  • 1989 - 1992 Kumamoto University School of Pharmacy
  • - 1992 Kumamoto University Faculty of Pharmaceutical Science
Professional career (1):
  • 薬学博士 (熊本大学)
Work history (10):
  • 2016/04 - 現在 Kanazawa University Cancer Research Institute
  • 2005 - 2016 金沢大学がん研究所(2012年よりがん進展制御研究所に名称変更) 助教
  • 2005 - 2005 京都大学医学研究科 研究員(学術研究振興)
  • 2003 - 2005 京都大学医学研究科先端領域融合医学研究機構 助手(特任)
  • 2002 - 2003 Kyoto University Faculty of Medicine
Show all
Association Membership(s) (1):
日本癌学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page